Stemtech Signs Merger Agreement With Seacret Direct, Now VIAGO
NAPLES, Florida -- December 4, 2024
Stemtech Corporation has signed an agreement to complete its previously announced merger with Seacret Direct, which now operates as VIAGO.
Under the agreement, Stemtech will issue 13 million preferred shares with a stated value of 2.50 dollars per share. Closing is subject to an audit of Seacret and other conditions. Stemtech said the combination is expected to double its revenue.
Stemtech also filed a Form 8-K on the agreement.
More StemTech news
Stemtech CFO James Cardwell Resigns; Shrilakshmi Vadlapatla Named CFO
Stemtech Corporation said in a Form 8-K that James Cardwell resigned as chief financial officer on April 11, 2025, and that its board appointed Shrilakshmi Vadlapatla as CFO at...
Stemtech Drops Eevia Health Takeover Plan, Seeks Nordic SME Listing for Viago Merger
Stemtech Corporation said in a Form 8-K that it has terminated its non-binding letter of intent for a proposed reverse takeover of Eevia Health Plc. The company said that after...
Stemtech Names John Meyer President and Chief Operating Officer
Stemtech Corporation appointed John W. Meyer president and chief operating officer, and said he would also sit on the board. Meyer joined the company in 2006 and had already been...
StemTech Completes Reverse Merger and Becomes the Public Operating Company
Globe Net Wireless Corp. reported that on August 19, 2021 it closed a merger agreement with privately held Stemtech Corporation. The public company acquired all of the Stemtech...